Skip to main content

Table 8 Multivariable model of associated factors of 5-year mortality in STEMI and NSTEMI

From: Clinical characteristics, management, and 5-year survival compared between no standard modifiable risk factor (SMuRFless) and ≥ 1 SMuRF ACS cases: an analysis of 15,051 cases from Pakistan

Variables

STEMI

NSTEMI

N = 3379

N = 3113

Adjusted Hazard ratio

Adjusted hazard ratio

(95% CI)

(95% CI)

SMuRFless

0.6 (0.4, 0.9)

0.9 (0.5, 1.5)

≥ 1 SMuRF

1

1

Age

  

≤ 50

1

1

> 50

2.9 (1.9, 4.5)

2.1 (1.3, 3.4)

Women

1.0 (1.7, 1.5)

1.4 (1.0, 2.0)

Men

1

1

Killip class

  

1

1

1

2

1.8 (1.2, 2.6)

1.8 (1.1, 2.8)

3

3.0 (1.9, 4.7)

3.6 (2.5, 5.3)

4

2.0 (1.0, 3.8)

0.6 (0.1, 4.9)

Number of vessels with coronary artery disease

  

None

1

1

Single

1.4 (0.8, 2.3)

1.5 (1.0, 2.4)

Double

1.5 (0.8, 2.7)

2.1 (1.2, 3.5)

Triple

1.9 (1.0, 3.6)

1.5 (0.9, 2.5)

ACE-I/ARB prescribed at discharge

0.6 (0.4, 0.8)

0.7 (0.5, 1.0)

Aspirin prescribed at discharge

0.8 (0.4, 1.7)

1.0 (0.5, 2.0)

Statin prescribed at discharge

0.7 (0.4, 1.3)

1.3 (0.7, 2.5)

Beta-blockers prescribed at discharge

0.9 (0.5, 1.5)

0.9 (0.6, 1.5)

  1. ACS = Acute Coronary Syndrome
  2. ACE-I/ARB = Angiotensin converting enzymes/Angiotensin Receptor Blocking agent
  3. SMuRF = Standard Modifiable Risk Factor